Lower risk Drug recall · FDA · Published March 4, 2025

Sun Pharmaceutical Gabapentin Capsules Recall: Cross Contamination Risk

Sun Pharmaceutical recalls 500-count and 1000-count Gabapentin 400mg capsules due to cross contamination risk. Affected lots expire March 2025. Consumers should check NDC codes and lot numbers.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0312-2025Drug Sun Pharmaceutical ›

Lower-risk recall

Cross Contamination

Take action

Contact the company

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way · Princeton, NJ 08540-6620

✎ GovInfoNow plain-language explainer

Sun Pharmaceutical is recalling certain Gabapentin 400mg capsules that may have cross contamination. This could lead to unintended medication interactions if the capsules are taken without proper cleaning. The recall affects specific lot numbers and packaging sizes. Read more at govinfonow.com/recall/32251-sun-pharmaceutical-gabapentin-capsules-recall-cross-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32251-sun-pharmaceutical-gabapentin-capsules-recall-cross-contamination-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0312-2025

Cite this page

“Sun Pharmaceutical Gabapentin Capsules Recall: Cross Contamination Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32251-sun-pharmaceutical-gabapentin-capsules-recall-cross-contamination-risk. Based on FDA recall #D-0312-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0312-2025%22&limit=1).

The FDA announced on March 4, 2025, that Sun Pharmaceutical is voluntarily recalling Gabapentin Capsules, USP 400 mg due to cross-contamination risks. The recall affects 852 bottles distributed nationwide.

How to tell if you have it

Brand: Sun Pharmaceutical
Product: Gabapentin Capsules, USP 400 mg
Packaging: 500-count bottles (NDC 62756-139-05) and 1000-count bottles (NDC 62756-139-04)
Lot codes: HAD1712B and HAD1712C
Expiration dates: 03/2025
Quantity: 852 bottles

The hazard

The recall is due to cross-contamination of the Gabapentin Capsules. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Sun Pharmaceutical has 93 other recalls on record since May 21, 2013. Other recent recalls include Sun Pharmaceutical Nystatin Cream (September 14, 2026) and Sun Pharmaceutical Carbamazepine Tablets (August 3, 2026). Other recent recalls of similar products include Golden State Medical Supply Primidone Tablets (April 27, 2026), Lannett Primidone Tablets (April 24, 2026), and Amerisource Health Primidone Tablets (May 1, 2026).

How to tell if you have this one

Check for 500-count bottles with NDC 62756-139-05 or 1000-count bottles with NDC 62756-139-04. The lot numbers are HAD1712B (expiring March 2025) or HAD1712C (expiring March 2025).

Brand
Sun Pharmaceutical
Category
Drug

FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Classification
Class III
Status
Ongoing
Distribution
Nationwide in the USA
NDC
62756-137-02, 62756-137-03, 62756-137-05, 62756-137-04, 62756-137-01, 62756-138-02, 62756-138-03, 62756-138-05, 62756-138-04, 62756-138-01, 62756-139-02, 62756-139-03, 62756-139-05, 62756-139-04, 62756-139-01, 62756-202-01, 62756-202-03, 62756-204-01, 62756-204-03

Recall number	Product, codes & lots	Quantity
D-0311-2025	Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, NDC 62756-138-04, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.; Lot # a) HAD1458A, Exp. date 04/2025, HAD2718A, Exp. date 07/2025, b) HAD3432A, exp. date 08/2025	12,876 bottles
D-0312-2025	Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.; Lot # a) HAD1712B, Exp. date 03/2025 b) HAD1712C, exp. date 03/2025	852 bottles

Based on the official FDA remedy

What to do — step by step

Check Product Details
Identify the NDC code (62756-139-05 for 500-count bottles or 62756-139-04 for 1000-count bottles) and lot number (HAD1712B or HAD1712C) on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 43 days after the firm started it.

Mar 4, 2025Firm started the recall
Apr 4, 2025FDA classified it Class III
Apr 16, 2025Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Do I need to stop using the capsules?

No, the recall does not require stopping use immediately. However, you should check the product details to confirm if it is recalled.

Similar recalls

Other Sun Pharmaceutical recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/32251-sun-pharmaceutical-gabapentin-capsules-recall-cross-contamination-risk">Sun Pharmaceutical Gabapentin Capsules Recall: Cross Contamination Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0312-2025 (March 4, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0312-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.